Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

Blood cancer journal·2026
Same author

Comprehensive landscape of secondary cytogenetic and molecular genetic events in multiple myeloma patients at diagnosis.

Leukemia·2026
Same author

The clinical relevance of sole loss of chromosome Y in myeloid neoplasms.

Blood cancer journal·2026
Same author

How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

Leukemia·2026
Same author

IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALL.

HemaSphere·2026
Same author

Genetic characterization of AML defined by differentiation shows a high frequency of DDX41 mutations.

British journal of haematology·2026

Related Experiment Video

Updated: Jun 26, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.7K

Artificial intelligence in hematological diagnostics: Game changer or gadget?

Wencke Walter1, Christian Pohlkamp1, Manja Meggendorfer1

  • 1MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377 München, Germany.

Blood Reviews
|October 14, 2022
PubMed
Summary

This review examines how machine learning tools are transforming blood disease diagnosis. It explains how these systems help identify abnormal cells and interpret genetic data while highlighting the need for clinicians to understand these technologies to avoid errors.

Keywords:
Artificial intelligenceHematological diagnosticsMachine learningPrecision medicineTransfer learningmachine learningclinical decision supporthematology diagnosticsdigital pathology

Frequently Asked Questions

More Related Videos

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.2K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.6K

Related Experiment Videos

Last Updated: Jun 26, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.7K
Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.2K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.6K

Area of Science:

  • Computational pathology within hematological diagnostics
  • Clinical applications of artificial intelligence in medicine

Background:

Current clinical workflows for blood disorders face significant bottlenecks in manual data interpretation and cell classification. Prior research has shown that automated systems offer potential improvements in diagnostic speed and accuracy. That uncertainty drove the need for a clearer understanding of how these computational tools function in practice. No prior work had resolved the gap between technical development and routine clinical application for hematologists. This article addresses the integration of automated models into standard diagnostic procedures. It distinguishes between established manual methods and emerging digital support systems. The authors emphasize that the efficacy of these tools depends heavily on user proficiency. This review provides the necessary context for clinicians to evaluate these new technologies effectively.

Purpose Of The Study:

The aim of this review is to provide hematologists with a comprehensive overview of machine learning techniques. The authors address the specific problem of integrating automated systems into routine clinical practice. They seek to clarify how these tools support decision-making for blood disease diagnosis. The motivation for this work stems from the rapid development of computational diagnostic models. The authors identify a need for clinicians to understand the general concepts behind these systems. This study explores the current implementations of machine learning in various diagnostic subfields. The researchers aim to bridge the gap between technical innovation and practical application. They intend to help specialists judge the utility of new diagnostic software correctly.

Main Methods:

The review approach involves a systematic examination of current machine learning implementations in clinical settings. The authors evaluate various computational strategies used for cell classification and genetic data analysis. This study synthesizes evidence from existing literature regarding diagnostic performance. The researchers categorize different technical frameworks based on their specific applications in blood disease identification. The review process focuses on identifying both the capabilities and the inherent constraints of these digital tools. The authors analyze how these systems support decision-making processes for specialists. This methodology emphasizes the practical requirements for clinicians to engage with new software. The study provides a structured overview of the current landscape of digital diagnostic support.

Main Results:

Key findings from the literature indicate that machine learning models effectively perform automatic cell differentiation. The authors report that these systems reliably detect malignant cell populations in patient samples. The review highlights that computational tools support complex tasks like chromosome banding analysis. The literature suggests that these models contribute to earlier disease detection and improved prognosis. The researchers note that the effectiveness of these tools relies on the user's ability to interpret outputs. The findings show that various diagnostic subfields, such as molecular genetics, benefit from these automated approaches. The literature confirms that these systems are currently being integrated into routine practice. The authors observe that the potential for misapplication remains a critical concern despite the high performance of these tools.

Conclusions:

The authors propose that machine learning will become a standard component of future hematological practice. They suggest that clinicians must acquire foundational knowledge to ensure the safe deployment of these systems. The synthesis indicates that automated tools currently assist in cell differentiation and genetic analysis. The researchers highlight that misapplication remains a significant risk to patient outcomes. The review implies that human expertise remains vital for interpreting complex computational outputs. The authors conclude that understanding underlying concepts prevents the misuse of diagnostic software. The synthesis suggests that ongoing challenges must be addressed before full integration occurs. The researchers maintain that these systems serve as decision support rather than replacements for specialists.

The researchers propose that these systems aid in differentiating blood cells, identifying malignant populations, and interpreting genetic variants. Unlike manual methods, these models offer automated support for chromosome banding analysis, which helps clinicians achieve earlier disease detection and more accurate prognostic assessments.

The authors describe machine learning as a set of computational techniques that enable systems to learn from data. This concept differs from traditional rule-based software because it allows for the identification of complex patterns in large datasets, such as those found in cytogenetics or molecular genetics.

The researchers state that a basic understanding of these concepts is necessary to prevent the misinterpretation of results. While automated tools provide significant advantages, the authors argue that clinicians must grasp how these systems function to avoid the risks associated with improper tool application.

The authors examine how these models function across various diagnostic subfields, including cytogenetics and molecular genetics. They emphasize that the role of these data-driven approaches is to support human decision-making rather than replace the clinical judgment of the hematologist.

The researchers identify several limitations, including the risk of misapplication and the potential for incorrect interpretation of findings. They contrast these challenges with the benefits of early detection, noting that even highly advanced tools can become ineffective if users lack sufficient technical knowledge.

The authors suggest that the future of clinical practice will inevitably involve the integration of these systems. They conclude that the long-term success of this transition depends on the ability of specialists to critically evaluate and correctly apply new technological developments in their daily work.